Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Conference News

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Shelley Wood

November 19, 2020

News Conference News VIVA 2020

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

L.A. McKeown

November 11, 2020

News Conference News VIVA 2020

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

L.A. McKeown

November 09, 2020

News Conference News TCT 2020

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

L.A. McKeown

October 22, 2020

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2020

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

L.A. McKeown

October 18, 2020

News Industry News

CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI

October 17, 2020

News Conference News TCT 2020

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

Michael O'Riordan

October 17, 2020

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

News Conference News TCT 2020

OCT Proves Predictive in Diabetic Patients, Even in FFR-Negative Lesions

Shelley Wood

October 14, 2020

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Industry News

Enrolment initiated in World’s First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

August 28, 2020

News Daily News

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Caitlin E. Cox

July 10, 2020

News Daily News

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

L.A. McKeown

July 02, 2020

News Conference News EuroPCR 2020

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

Todd Neale

June 30, 2020

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Caitlin E. Cox

June 18, 2020

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Caitlin E. Cox

May 08, 2020

Advertisement

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

OCT Proves Predictive in Diabetic Patients, Even in FFR-Negative Lesions

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

Enrolment initiated in World’s First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content